iCAD is a global leader in advanced breast cancer detection solutions built on artificial intelligence that empower radiologists to find cancers earlier while improving reading workflow. Our Breast Health Solutions suite delivers powerful detection and workflow solutions for 2D and 3D mammography.
Wednesday, December 14, 2022 | 3:00 pm ET • 12:00 pm PT
Chirag Parghi, MD
Chief Medical Officer, Solis Mammography
Our Breast AI Suite offers a triple threat of clinically proven cancer detection, density assessment, and risk evaluation solutions, expertly designed to accelerate discovery and improve outcomes. See why leading imaging facilities worldwide trust our technologies to detect cancer and stop it in its tracks – streamlining workflow, improving accuracy, and personalizing results like never before.
iNFORMED - BlogInform, connect and engage. We invite you to engage with us to participate on the topic of cancer detection solutions, patient stories, clinical expertise.View BlogMedia SpotlightThe New Normal - The Imaging Landscape in Late-Stage Pandemic DaysView ArticleClinical FeatureImproving reading time of digital breast tomosynthesis with concurrent computer aided detection.View White Paper
© iCAD Inc. All rights reserved. iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are registered trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.